Back to Search
ANTHONY LUCCI, M.D.
M.D.
Surgical Oncology Physician
NPI: 1487740304IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgical Oncology PhysicianPrimary
Surgery — Surgical Oncology
Code: 2086X0206X
J3347(TX)
Education
TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.
PMID 18663571·Breast Cancer Res Treat·2009
8-other
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
PMID 17485711·J Clin Oncol·2007
4-observational
Assessment of the current Medicare reimbursement system for breast cancer operations.
PMID 15545504·Ann Surg Oncol·2004
8-other
Assessment of knowledge of melanoma risk factors, prevention, and detection principles in Texas teenagers.
PMID 11341796·J Surg Res·2001
8-other
National practice patterns of sentinel lymph node dissection for breast carcinoma.
PMID 11294401·J Am Coll Surg·2001
8-other
Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery.
PMID 19427625·Am J Surg·2009
2-rct
Lymph node ratio predicts disease-specific survival in melanoma patients.
PMID 19309746·Cancer·2009
8-other
A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
PMID 19482312·J Surg Res·2009
7-preclinical
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.
PMID 18327638·Breast Cancer Res Treat·2009
3-trial
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.
PMID 19195040·Cancer·2009
4-observational
Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.
PMID 19280264·Ann Surg Oncol·2009
8-other
Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
PMID 18498876·J Surg Res·2008
8-other
Orthopedic surgery implications of breast cancer.
PMID 18533804·Expert Rev Anticancer Ther·2008
6-review
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?
PMID 18457326·Cancer·2008
8-other
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
PMID 18564433·World J Surg Oncol·2008
2-rct
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
PMID 18436181·Am J Surg·2008
8-other
Melanoma adrenal metastasis: natural history and surgical management.
PMID 18206850·Am J Surg·2008
8-other
Is axillary dissection needed when the sentinel node is positive? No: it is time to rethink axillary lymph node dissection when the sentinel node is positive.
PMID 18264979·J Surg Oncol·2008
8-other
A promising microbiological test for the diagnosis of drowning.
PMID 18980820·Forensic Sci Int·2008
8-other
Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
PMID 17944570·Expert Rev Anticancer Ther·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1487740304
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile